Demo Sign up Log In

Kymera Therapeutics Inc (KYMR)

Cash Conversion Ratio

0.89×

Quarterly · Period ending: Jun 30, 2026

KYMR Cash Conversion Ratio

Latest reported0.89×period endingJun 30, 2026

Latest reported0.89×period endingJun 30, 2026

KYMR Quarterly Cash Conversion Ratio (1.11× → 0.89×)

Latest values, visible window

High-resolution chart · PNG

KYMR cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.891×
Mar 31, 2026	1.2895×
Dec 31, 2025	0.7682×
Sep 30, 2025	0.3321×
Jun 30, 2025	0.7907×
Mar 31, 2025	1.214×
Dec 31, 2024	0.8865×
Sep 30, 2024	0.8002×
Jun 30, 2024	1.1323×
Mar 31, 2024	0.9678×
Dec 31, 2023	0.2492×
Sep 30, 2023	0.7514×
Jun 30, 2023	1.1862×
Mar 31, 2023	1.1722×
Dec 31, 2022	1.1447×
Sep 30, 2022	0.8259×
Jun 30, 2022	0.9867×
Mar 31, 2022	1.1116×
Dec 31, 2021	1.1461×
Sep 30, 2021	1.3143×
Jun 30, 2021	1.2627×
Mar 31, 2021	1.7581×
Dec 31, 2020	1.6953×
Sep 30, 2020	-16.1856×
Jun 30, 2020	1.0914×
Mar 31, 2020	1.2305×
Dec 31, 2019	0.9554×
Sep 30, 2019	1.1108×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.